Metagenomi, Inc.

Contributing Author

Recent Articles by Metagenomi, Inc.

Jan-12	Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook MGX GlobeNewswire
Dec-01	Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference MGX -8.57% GlobeNewswire
Nov-17	Metagenomi to Present at Jefferies Global Healthcare Conference in London MGX GlobeNewswire
Nov-11	Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates MGX -15.45% MGX GlobeNewswire
Nov-11	Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development MGX -15.45% MGX GlobeNewswire
Aug-12	Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results MGX GlobeNewswire
Aug-11	Metagenomi Appoints Laurence Reid, PhD to its Board of Directors MGX GlobeNewswire
May-14	Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025 MGX -6.25% GlobeNewswire
May-13	Metagenomi Reports Business Updates and First Quarter 2025 Financial Results MGX GlobeNewswire
May-02	Metagenomi to Present at Upcoming Scientific Meetings MGX +8.05% GlobeNewswire